Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...
The US Food and Drug Administration (FDA) has issued a warning letter to Purolea Cosmetics Lab for several violations of Good ...
The US Food and Drug Administration (FDA) has called on its Pharmacy Compounding Advisory Committee to discuss whether a ...
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
The US Food and Drug Administration (FDA) is asking makers of testosterone replacement therapy (TRT) products to consider ...
European authorities have recommended changes to the regulatory framework to keep pace with the progress of the ...
The US Food and Drug Administration (FDA) has notified more than 2,200 medical product manufacturers and researchers to disclose clinical trial results as required by law. The agency said it is part ...
The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing ...
Office of Prescription Drug Promotion (OPDP) has stepped up its enforcement efforts regarding prescription drug promotion, ...
A US Food and Drug Administration (FDA) official acknowledged significant regulatory hurdles in the development of products ...
The International Medical Device Regulators Forum (IMDRF) has released a draft technical document to create a harmonized set ...
The US Food and Drug Administration (FDA) has announced that starting on 1 October 2026, manufacturers must submit adverse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results